Anti-inflammatory and nephroprotective activity of Juglans mollis against renal ischemia-reperfusion damage in a Wistar rat model
- Jonathan Perez-Meseguer,
- Liliana Torres-González,
- Jorge Aurelio Gutiérrez-González,
- ,
- Homero Zapata-Chavira,
- Noemi Waksman-De Torres
- Universidad Autonoma de Nuevo Leon
Open access
Publication metrics
Metrics
Abstract
Background: Oxidative stress and the inflammatory process are involved in ischemia-reperfusion (I/R) injury. Juglans mollis has been reported as having antioxidant activity, which could attenuate the damage caused by I/R. We evaluated whether a methanolic extract of Juglans mollis (JM) exhibits nephroprotective activity in a Wistar rat model of I/R injury. Methods: Four groups of six rats were used: Sham, I/R, JM, and JM + I/R. Two groups were dosed with JM (300 mg/kg) for 7 days before I/R. I/R injury was induced by clamping the renal hilums for 45 min and then reperfusing the kidneys for 15 h. Blood samples were taken to evaluate the levels of alanine aminotransferase (ALT), blood urea nitrogen, creatinine, superoxide dismutase (SOD), malondialdehyde (MDA), interleukin 1β (IL-1β), IL-6, and tumor necrosis factor α (TNF-α). Results: The levels of creatinine, ALT, MDA, IL-1β, IL-6, and TNF-α were lower in JM + I/R than in I/R rats, whereas SOD level only was higher in JM + I/R than in Sham rats. No biochemical or histological damage was observed in JM rats compared with Sham rats; however, less histological damage was observed in JM + I/R rats compared with I/R rats. Conclusions: To our knowledge, this is the first report of nephroprotective activity of J. mollis against damage induced by I/R. This activity may be related to decreased levels of proinflammatory cytokines (IL-1β, IL-6, and TNF-α) and modulation of oxidative stress markers (SOD and MDA) observed in the present study.
Publication Information
Output type
Original language
EnglishArticle number
186Pages from-to (Number of pages)
Pages 186Journal (Volume, Issue Number)
BMC Complementary and Alternative Medicine (Volume 19, Issue 1)Publication milestones
- Published - 26/07/2019
Publication status
ISSN
1472-6882Publication IDs
- Scopus: 85069773598
- PubMed: 31349827
